Gevorg Tamamyan, Editor-in-Chief of OncoDaily, President of SIOP Asia and POEM Group, CEO at Immune Oncology Research Institute, Chair of the Department of Hematology and Pediatric Oncology at Yerevan State Medical University, shared a post on LinkedIn։
“OncoCorridor: Connecting patients with cancer in conflict zones to treatment centers worldwide read the paper in Lancet Oncology.
This was published right before our yesterday’s High-Level opening in Geneva, where we had amazing people and discussions. The photoreport of the event is coming next.”
Title: OncoCorridor: connecting patients with cancer in conflict zones to treatment centres worldwide
Authors: Jemma Arakelyana, James Adnan Nassura, Emma Tadevosyana, Gevorg Tamamyan
Other articles featuring Gevorg Tamamyan on OncoDaily.